Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 361
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Pro-inflammatory cells sustain leukemic clonal expansion in T-cell large granular lymphocyte leukemia 2024 Gasparini V. R.Teramo A.Calabretto G.Rampazzo E.Carraro S.Trimarco V.Trentin L.Facco M.Zambello R. + HAEMATOLOGICA - -
The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune disorders 2024 Calabretto, GiuliaTeramo, AntonellaGasparini, Vanessa RebeccaRampazzo, ElisaZambello, Renato + BLOOD CANCER JOURNAL - -
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective real-world experience with 200 cases outside of controlled clinical trials 2024 Zambello, RenatoTarantini, GiuseppeRizzi, Rita + HAEMATOLOGICA - -
Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma 2024 Zambello, Renato + BLOOD - -
A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients: a report from the Triveneto Myeloma Working Group 2024 Sartori, RobertoPavan, LauraZambello, Renato + ANNALS OF HEMATOLOGY - -
Real-world use of carfilzomib combined with lenalidomide and dexamethasone in patients with multiple myeloma in Europe and Israel 2023 Zambello, Renato + EJHAEM - -
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial 2023 Zambello, Renato + ECLINICALMEDICINE - -
Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL 2023 Zambello, Renato + BLOOD ADVANCES - -
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies 2023 D’Amore, FabioPavan, LauraPiazza, FrancescoPravato, StefanoScapinello, GretaVianello, FabrizioZambello, RenatoPadoan, AndreaTrentin, LivioVisentin, Andrea + FRONTIERS IN ONCOLOGY - -
Imaging minimal residual disease evaluation in multiple myeloma using [18F]FDG PET/MRI 2023 Crimì, FilippoPavan, LauraCabrelle, GiulioCecchin, DiegoZambello, Renato + LEUKEMIA & LYMPHOMA - -
Not all LGL leukemias are created equal 2023 Calabretto, GiuliaGasparini, Vanessa RebeccaTeramo, AntonellaZambello, Renato + BLOOD REVIEWS - -
Tγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients 2023 Teramo A.Calabretto G.Gasparini V. R.Zambello R. + BLOOD - -
Waldenström Macroglobulinemia in Very Elderly (≥75-year-old) Patients: A 33-year-retrospective Cohort Study in an Italian University Hospital 2023 Scapinello, GretaGrassi, AngelaVisentin, AndreaPavan, LauraManni, SabrinaVianello, FabrizioBriani, ChiaraZambello, RenatoTrentin, LivioPiazza, Francesco + HEMASPHERE - -
Lenalidomide-based triplet regimens in first relapsed multiple myeloma patients: real-world evidence from a propensity score matched analysis 2023 Zambello, Renato + HAEMATOLOGICA - -
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials 2022 Zambello, Renato + HEMATOLOGICAL ONCOLOGY - -
Identification of novel STAT5B mutations and characterization of TCRβ signatures in CD4+ T-cell large granular lymphocyte leukemia 2022 Teramo A.Gasparini V. R.Vicenzetto C.Calabretto G.Facco M.Semenzato G.Zambello R. + BLOOD CANCER JOURNAL - -
All that glitters is not LGL Leukemia 2022 Teramo, AntonellaCalabretto, GiuliaGasparini, Vanessa RebeccaZambello, Renato + LEUKEMIA - -
LGL Clonal Expansion and Unexplained Cytopenia: Two Clues Don't Make an Evidence 2022 Calabretto, GiuliaZambello, Renato + CANCERS - -
Experts' consensus on the definition and management of high risk multiple myeloma 2022 Zambello, Renato + FRONTIERS IN ONCOLOGY - -
A bone-based 3D scaffold as an in-vitro model of microenvironment–DLBCL lymphoma cell interaction 2022 Ceccato J.Piazza M.Pizzi M.Manni S.Piazza F.Caputo I.Cinetto F.Pisoni L.Scarpa R.Zambello R.Tos A. P. D.Trentin L.Semenzato G.Vianello F. + FRONTIERS IN ONCOLOGY - -
Mostrati risultati da 1 a 20 di 361
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile